Advertisement

Digestive Diseases and Sciences

, Volume 54, Issue 3, pp 538–546 | Cite as

The Effects of Combined Treatment of Antioxidants on the Liver Injury in STZ Diabetic Rats

  • Selda Gezginci-OktayogluEmail author
  • Hasan Basaraner
  • Refiye Yanardag
  • Sehnaz Bolkent
Original Article

Abstract

The aim of this study was to examine whether an antioxidant combination of vitamin C, vitamin E, and sodium selenate (Se) has an effect on the liver of diabetic rats. Vitamin C, vitamin E, and Se were administered for 30 days to streptozotocin (STZ)-induced diabetic and control groups. In the STZ diabetic group, blood glucose levels, liver lipid peroxidation (LPO), and nonenzymatic glycosylation (NEG) levels increased, but blood and liver glutathione levels decreased. On the other hand, combined antioxidant treatment reversed these effects. In the diabetic group, some degenerative changes were observed by light and electron microscopic examinations, but the degenerative changes decreased in the diabetic group given antioxidant combination. Proliferating cell nuclear antigen (PCNA) immunohistochemistry showed that the number of proliferative hepatocytes increased significantly with antioxidant treatment. It was concluded that combined treatment with vitamin C, vitamin E, and Se has a curative effect against the hepatotoxicity produced by STZ-induced diabetes.

Keywords

Liver STZ-diabetes Selenium Vitamin C Vitamin E 

Notes

Acknowledgment

This study was supported by the Research Fund of Istanbul University. Project Number No. T-676/190299.

References

  1. 1.
    Robertson RP (2004) Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 279:42351–42354PubMedCrossRefGoogle Scholar
  2. 2.
    Arulselvan P, Subramanian SP (2007) Beneficial effects of Murraya koenigii leaves on antioxidant defense system and ultra structural changes of pancraetic β-cells in experimental diabetes in rats. Chem Biol Int 165:155–164CrossRefGoogle Scholar
  3. 3.
    Lee DM, Hoffman WH, Carl GF, Khichi M, Cornwell PE (2002) Lipid peroxidation and antioxidant vitamins prior to, during, and after correction of diabetic ketoacidosis. J Diabetes Complicat 16:294–300PubMedCrossRefGoogle Scholar
  4. 4.
    Ceriello A (2003) New insights on oxidative stress and diabetic complications may lead to a “causal” antioxidant therapy. Diabetes Care 26:1589–1596PubMedCrossRefGoogle Scholar
  5. 5.
    Maxwell SR, Thomason H, Sandler D (1997) Antioxidant status in patients in uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus. Eur J Clin Invest 27:484–490PubMedCrossRefGoogle Scholar
  6. 6.
    Chance B, Sies H, Boveris A (1979) Hydroperoxide metabolism in mammalian organs. Physiol Rev 59:527–605PubMedGoogle Scholar
  7. 7.
    Halliwell B, Gutteridge JMC (1999) Free radicals, other reactive species and disease. In: Halliwell B, Gutteridge JMC (eds) The free radicals in biology and medicine. Oxford University Press, New York, pp 639–645Google Scholar
  8. 8.
    Upritchard JE, Sutherland WH, Mann JI (2000) Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diabetes Care 23:733–738PubMedCrossRefGoogle Scholar
  9. 9.
    Guerrero-Romero F, Rodríguez-Morán M (2005) Complementary therapies for diabetes: The case for chromium, magnesium, and antioxidants. Arch Med Res 36:250–257PubMedCrossRefGoogle Scholar
  10. 10.
    Soni MG, Ramaiah SK, Mumtaz MM, Clewell H, Mehendale HM (1999) Toxicant-inflicted injury and stimulated tissue repair are opposing toxicodynamic forces in predictive toxicology. Regul Toxicol Pharmacol 29:65–174CrossRefGoogle Scholar
  11. 11.
    Jound A, Lambert E, Stauffacher W, Renold AE (1969) Diabetogenic action of streptozotocin. Relationship of dose to metabolic response. J Clin Invest 48:2129–2139CrossRefGoogle Scholar
  12. 12.
    Relander A, Raiha CE (1963) Differences between the enzymatic and o-toluidine methods of blood glucose determination. Scand J Clin Lab Invest 15:221–224CrossRefGoogle Scholar
  13. 13.
    Beutler E, Duron O, Kelly BM (1963) Improved method for the determination of blood glutathione. J Lab Clin Med 61:882–888PubMedGoogle Scholar
  14. 14.
    Ledwozyw A, Michalak J, Stepien A, Kadziolka A (1986) The relationship between plasma triglycerides, cholesterol, total lipids and lipid peroxidation products during human atherosclerosis. Clin Chim Acta 155:275–283PubMedCrossRefGoogle Scholar
  15. 15.
    Beutler E (1975) Glutathione in red cell metabolism: a manual of biochemical methods. Grune and Stratton, New York, pp 112–114Google Scholar
  16. 16.
    Parker KM, England JD, Casto JD, Hessel K, Goldstein PE (1981) Improved colometric assay for glycolylated hemoglobin. Clin Chem 27:669–672PubMedGoogle Scholar
  17. 17.
    Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265–275PubMedGoogle Scholar
  18. 18.
    Wang T, Fonetenot RD, Soni MG, Bucci TJ, Mehendale HM (2000) Enhanced hepatotoxicity and toxic outcome of thioacetamide in streptozotocin-induced diabetic rats. Toxicol Appl Pharmacol 166:92–100PubMedCrossRefGoogle Scholar
  19. 19.
    Gao LH, Liu WP, Wang BL, Li L, Xie MJ, Li YR, Chen ZH, Chen XZ (2006) Effects of bis(α-furancarboxylato)oxovanadium (IV) on non-diabetic and streptozotocin-diabetic rats. Clin Chim Acta 368:173–178PubMedCrossRefGoogle Scholar
  20. 20.
    Arun N, Nalini N (2002) Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats. Plants Foods Hum Nutr 57:41–52CrossRefGoogle Scholar
  21. 21.
    Gupta D, Raju J, Prakash JR, Baquer NZ (1999) Changes in the lipid profile, lipogenic and related enzymes in the livers of experimental diabetic rats: Effect of insulin and vanadate. Diabetes Res Clin Pract 46:1–7PubMedCrossRefGoogle Scholar
  22. 22.
    Sochor M, Baquer NZ, Mclean P (1985) Glucose over and underutilization in diabetes: Comperative studies on the change in activities of enyzmes of glucose metabolism in rat kidney and liver. Mol Physiol 7:51–68Google Scholar
  23. 23.
    Ravi K, Ramachandran B, Subramanian S (2004) Protective effect of Eugenia jambolana seed kernel on tissue antioxidants in streptozotocin-induced diabetic rats. Biol Pharm Bull 27:1212–1217PubMedCrossRefGoogle Scholar
  24. 24.
    Baynes JW, Thorpe SR (1999) Role of oxidative stress in diabetic complications. A new perspective on an old paradigm. Diabetes 48:1–9PubMedCrossRefGoogle Scholar
  25. 25.
    Menegola E, Broccia ML, Prati M, Ricolfi R, Giovani E (1996) Glutathione status in diabetes-induced embryopathies. Biol Neonatane 69:293–297CrossRefGoogle Scholar
  26. 26.
    Yanardag R, Ozsoy-Sacan O, Orak H, Ozgey Y (2005) Protective effects of glurenorm (gliquidone) treatment on the liver injury of experimental diabetes. Drug Chem Toxicol 28:483–497PubMedCrossRefGoogle Scholar
  27. 27.
    Anuradha CV, Selvam R (1993) Effect of oral methionine on tissue lipid peroxidation and antioxidants in alloxan-induced diabetic rats. J Nutr Biochem 1:653–658Google Scholar
  28. 28.
    Panneerselvan SR, Govidasamy S (2004) Effect of sodium molybdate on the status of lipids, lipid peroxidation and antioxidant systems in alloxan-induced diabetic rats. Clin Chim Acta 345:93–98CrossRefGoogle Scholar
  29. 29.
    Pari L, Latha M (2005) Antidiabetic effect of Scoparia dulcis: Effect of lipid peroxidation in streptozotocin diabetes. Gen Physiol Biophys 24:13–26PubMedGoogle Scholar
  30. 30.
    Rajasekaran S, Sivagnanam K, Subramanian S (2005) Antioxidant effect of Aloe vera gel extract in streptozotocin-induced diabetes in rats. Pharmacol Rep 57:90–96PubMedGoogle Scholar
  31. 31.
    Rahimi R, Nikfar S, Larijani B, Abdollahi M (2005) A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother 59:365–373PubMedCrossRefGoogle Scholar
  32. 32.
    Girotti AW (1998) Lipid hydroperoxide generation, turnover, and effector action in biological systems. J Lipid Res 39:1529–1542PubMedGoogle Scholar
  33. 33.
    Sathishsekar D, Subramanian S (2005) Antioxidant properties of Momardica charantia (bitter gourd) seeds on streptozotocin induced diabetic rats. Asia Pac J Clin Nutr 14:153–158PubMedGoogle Scholar
  34. 34.
    Kesavulu MM, Rao BK, Giri R, Vijaya J, Subramanyam G, Apparao C (2001) Lipid peroxidation and antioxidant enzyme status in Type 2 diabetics with coronary heart disease. Diabetes Res Clin Pract 53:33–39PubMedCrossRefGoogle Scholar
  35. 35.
    Shimoi K, Okitsu A, Gren MHL, Lowe JH, Ohta T, Kaji K (2001) Oxidative DNA damage induced by high glucose and its suppression in human umbilical vein endothelial cells. Mutat Res 1:371–378Google Scholar
  36. 36.
    Oberley LW (1988) Free radicals and diabetes. Free Radic Biol Med 5:113–124PubMedCrossRefGoogle Scholar
  37. 37.
    Vlassara H, Bucala R, Striker L (1994) Pathogenic effects of advanced glycolisation: biochemical, biological and clinical implications for diabetes and aging. Lab Invest 70:138–151PubMedGoogle Scholar
  38. 38.
    Kakkar R, Mantha SV, Radhi J, Prasad K, Kalra J (1998) Increased oxidative stress in rat liver and pancreas during progression of streptozotocin induced diabetes. J Clin Invest 94:623–632Google Scholar
  39. 39.
    Yue DK, Mclennan S, Turtle JR (1983) Nonenzymatic glycosylation of tissue protein in diabetic in rat. Diabetologia 24:377–381PubMedGoogle Scholar
  40. 40.
    Can A, Akev N, Ozsoy N, Bolkent S, Arda BP, Yanardag R, Okyar A (2004) Effect of Aloe vera leaf gel and pulp extract the liver in type-II diabetic rat models. Biol Pharmacol Bull 27:694–698CrossRefGoogle Scholar
  41. 41.
    Ozsoy-Sacan O, Yanardag R, Orak H, Ozgey Y, Yarat A, Tunali S (2006) Effects of parsley (Petroselinum crispum) extract versus glibornuride on the liver of streptozotocin-induced diabetic rats. J Ethnopharmacol 104:175–181PubMedCrossRefGoogle Scholar
  42. 42.
    Yarat A, Yanardag R, Ozcelik F, Bapcum A, Emekli E (1998) Effect of vitamin B6 on lenses of diabetic rats. Indian J Exp Biol 36:1269–1272PubMedGoogle Scholar
  43. 43.
    Yanardag R, Tunali S (2006) Effect of vanadyl sulfate on the status of lipid parameters and on stomach and spleen tissues of streptozotocin-induced diabetic rats. Pharmacol Res 53:271–277PubMedCrossRefGoogle Scholar
  44. 44.
    Bolkent S, Bolkent S, Yanardag R, Mutlu O, Yildirim S (2006) Alteration in somatostatin cells and biochemical parameters following zinc supplemetation in gastrointestinal tissue of streptozotocin–induced diabetic rats. Acta Histochem Cytochem 39:9–15PubMedCrossRefGoogle Scholar
  45. 45.
    Koyuturk M, Tunali S, Bolkent S, Yanardag R (2005) Effects of vanadyl sulfate on liver of streptozotocin-induced diabetic rats. Biol Trace Elem Res 104:233–247PubMedCrossRefGoogle Scholar
  46. 46.
    Packer L, Landvik S (1990) Vitamin E in biological systems. In: Emerit I, Packer L, Auclair C (eds) The antioxidants in therapy and preventive medicine. Plenum Press, New York, pp 93–104Google Scholar
  47. 47.
    Yong IS, Torney JJ, Trimble ER (1992) The effect of supplementation on oxidative stress in the streptozotocin diabetic rat. Free Radic Biol Med 13:41–46CrossRefGoogle Scholar
  48. 48.
    Stoyanovsky DA, Wu D, Cedrebaum AI (1998) Intraction of hydroxyethyl radical with glutathione, ascorbic acid and α-tocopherol. Free Radic Biol Med 24:132–138PubMedCrossRefGoogle Scholar
  49. 49.
    Sthal W, Sies H (1997) Antioxidant defense vitamin E and C and carotenoids. Diabetes 46:14–18Google Scholar
  50. 50.
    Halliwell B, Gutteridge JMC (1996) Free radicals in biology and medicine. Clarendon Press, Oxford Google Scholar
  51. 51.
    Schrauzer GN (2000) Anticarcinogenic effect of selenium. Cell Mol Life Sci 57:1864–1873PubMedCrossRefGoogle Scholar
  52. 52.
    Naziroglu M, Dilsiz N, Cay M (1999) Protective role of intraperitoneally administered vitamins C and E and selenium on the levels of lipid peroxidation in the lens of rats made diabetic with streptozotocin. Biol Trace Elem Res 70:223–232PubMedCrossRefGoogle Scholar
  53. 53.
    Starzl TE, Porter KA, Kashiwagi N (1975) Portal hepatotophic factors, diabetes mellitus and acute liver atrophy, hypertrophy and regeneration. Surg Gynecol Obstet 141:843–888PubMedGoogle Scholar
  54. 54.
    Starzl TE, Porter KA, Kashiwagi N (1975) The effect of diabetes mellitus on portal blood hepatotrophic factors in dogs. Surg Gynecol Obstet 140:549–562PubMedGoogle Scholar
  55. 55.
    Shankar K, Vaidya VS, Apte UM, Manautou JE, Ronis MJJ, Bucci TJ, Mehendale HM (2003) Type 1 diabetic mice are protected from acetominophen hepatotoxicity. Toxicol Sci 73:220–234PubMedCrossRefGoogle Scholar
  56. 56.
    Soni MG, Mehendale HM (1998) Role of tissue repair in toxicologic interactions among hepatotoxic organics. Environ Health Perspect 106:1307–1317PubMedGoogle Scholar
  57. 57.
    Bollen M, Keppens S, Stalmans W (1998) Specific features of glycogen metabolism in the liver. Biochem J 336:9–31Google Scholar
  58. 58.
    Gannon MC, Nuttall FQ (1997) Effect of feeding, fasting and diabetes on liver glycogen synthase activity, protein an mRNA in rats. Diabetologia 40:758–763PubMedCrossRefGoogle Scholar
  59. 59.
    Prince PSM, Kamalakkannan N (2006) Rutin improves glucose homeostasis in streptozotocin diabetic tissues by altering glycolytic and gluconeogenic enzymes. J Biochem Mol Toxicol 20:96–102CrossRefGoogle Scholar
  60. 60.
    Betteridge DJ (2000) Diabetic dyslipidemia. Diabetes Obes Metab 1:S31–S36CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Selda Gezginci-Oktayoglu
    • 1
    Email author
  • Hasan Basaraner
    • 2
  • Refiye Yanardag
    • 2
  • Sehnaz Bolkent
    • 1
  1. 1.Faculty of Science, Department of BiologyIstanbul UniversityVezneciler, IstanbulTurkey
  2. 2.Faculty of Engineering, Department of ChemistryIstanbul UniversityAvcilar, IstanbulTurkey

Personalised recommendations